25 May 2013
Keywords: Ranbaxy, Daiichi Sankyo, Mexico, Licensing
Article | 12 October 2009
Japanese drug major Daiichi Sankyo’s portfolio of drugs is to be commercialized in Mexico through a recently created marketing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 October 2009
24 May 2013
© 2013 thepharmaletter.com